Addex Therapeutics Ltd
ADXNNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $4.39M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.56$11.97
- Volume (live)
- -
- Avg. volume (3M)
- 22.40K
Addex Therapeutics (ADXN) Stock Price & Financial Analysis
Addex Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.64 - $3.20 |
|---|---|
| 52-Week High | $11.97 |
| 52-Week Low | $2.56 |
| Open | $3.10 |
| Volume (last close) | 11.34K |
| Average Volume (3M) | 22.40K |
| Revenue (TTM) | 84.66K |
|---|---|
| Net Income (TTM) | -8.64M |
| Free Cash Flow (TTM) | -2.90M |
| EPS (TTM) | −$8.25 |
| Profit Margin | -10211.52% |
| Operating Margin | -3774.08% |
| Return on Equity (ROE) | -373.48% |
| Debt to Equity | 0.04 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 4.39M |
|---|---|
| Shares Outstanding | 1.45M |
| Price to Sales (P/S) | 51.87 |
| Price to Book (P/B) | 1.90 |
| EV/EBITDA | -0.76 |
| 50-Day MA | $3.99 |
|---|---|
| 200-Day MA | $6.10 |
| 1-Year Change | −72.42% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Addex Therapeutics at a Glance
As of the Oct 16, 2026 close, Addex Therapeutics (ADXN) has a market capitalization of $4.39M. The stock trades at 51.9× sales. Over the trailing twelve months it lost $8.64M on revenue of $84.66K and burned $2.90M of free cash flow. Revenue fell 9.2% year over year.
As of its latest reported balance sheet, it holds $930.62K in cash and securities against $93.99K of debt, a net cash position of $836.63K.
Addex Therapeutics does not currently pay a dividend.
The share price is down 72.4% over the past year. At $2.76 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $2.56 to $11.97, below its 200-day moving average of $6.10.
Frequently Asked Questions About Addex Therapeutics
What is the current stock price for ADXN?
As of the Oct 16, 2026 close, ADXN stock trades at $2.76. The 52-week range is $2.56–$11.97, with a day range of $2.64–$3.19.
What is the P/E ratio for ADXN?
The P/E ratio (Price-to-Earnings) for ADXN is shown in the Key Statistics section. This valuation metric helps compare Addex Therapeutics Ltd to industry peers.
Does ADXN pay dividends?
Addex Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ADXN?
Analyst ratings and recommendations for ADXN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ADXN?
As of the Oct 16, 2026 close, Addex Therapeutics's market capitalization is $4.0M, classifying it as a micro-cap company. Addex Therapeutics operates in the Healthcare sector within the Biotechnology industry.